Rite Aid Corporation (RAD) is scheduled to report second quarter 2019 earnings on Thursday. Analysts expect the company to report revenues of $5.37 billion, down 30% year-over-year, along with a loss of $0.01 per share. Weakness in the generic drug market has been negatively impacting the stock, which does not present a positive picture to … Continue reading Earnings Preview: Rite Aid might not turn a positive surprise